Carrel takes helm of AtriCure

Editorial Staff | November 02, 2012 | Cardiovascular Business | Heart Rhythm

AtriCure, a developer of cardiac surgical ablation systems for the treatment of atrial fibrillation and systems for the exclusion of the left atrial appendage, announced that Michael Carrel has been appointed as president and CEO, effective immediately.

Carrel was most recently the president and CEO of Vital Images, a medical imaging software company, from 2008 until it was sold to Toshiba in 2011. He stayed on as CEO of the new business unit within Toshiba until 2012, when the integration was completed. He originally joined Vital in January 2005 as chief operating and financial officer.

In August, AtriCure reported that longtime CEO David Drachman would resign Sept. 30.

Editorial Staff

Around the web

Health Imaging

Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business

What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Carrel takes helm of AtriCure

Related Content

Around the web